Forte Biosciences, Inc. (FBRX)

NASDAQ: FBRX · Real-Time Price · USD

10.98

-0.07 (-0.63%)

Sep 3, 2025, 11:16 AM - Market open

Forte Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Sep '25 Sep 3, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2020
Market Capitalization	196	145	30	21	32	467	Upgrade
Market Cap Growth	706.99%	386.30%	42.17%	-33.49%	-93.24%	-	Upgrade
Enterprise Value	91	129	-16	-23	-14	447	Upgrade
Last Close Price	11.05	22.71	20.54	25.00	53.50	910.25	Upgrade
PB Ratio	1.38	2.77	0.85	0.54	0.76	7.92	Upgrade
P/TBV Ratio	2.00	2.77	0.85	0.54	0.76	7.92	Upgrade
Quick Ratio	11.58	6.43	10.13	12.93	23.92	26.01	Upgrade
Current Ratio	11.74	6.76	10.46	13.06	24.19	26.52	Upgrade
Return on Equity (ROE)	-73.46%	-80.82%	-84.92%	-34.54%	-43.19%	-143.64%	Upgrade
Return on Assets (ROA)	-40.79%	-45.51%	-50.15%	-20.36%	-25.69%	-25.81%	Upgrade
Return on Capital (ROIC)	-47.25%	-52.11%	-54.78%	-21.61%	-26.72%	-27.47%	Upgrade
Earnings Yield	-21.54%	-24.44%	-105.42%	-66.09%	-68.75%	-9.95%	Upgrade
FCF Yield	-19.61%	-21.20%	-96.44%	-38.98%	-52.82%	-3.94%	Upgrade
Buyback Yield / Dilution	-340.93%	-130.90%	-81.61%	-24.45%	-89.81%	-249.05%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q